Chongqing Zhifei Biological Products (300122) Stock Price, Fundamentals & Analysis

What 300122 does

Chongqing Zhifei Biological Products (300122) is a biopharmaceutical company listed on the Shenzhen Stock Exchange stocks. It develops, produces, and distributes vaccines and biological products in China, including a recombinant COVID-19 vaccine, meningococcal vaccines, and the Vaccae mycobacterium injection. The company also provides cold-chain logistics services such as cold storage, refrigerated vehicles, and customs clearance for imported vaccines. It was founded in 2002 and is headquartered in Chongqing, China.

Key numbers explained

• 13.01 CNY is the current share price — the last traded price on the Shenzhen Stock Exchange.
• -3.2% is today’s price change, showing the stock is down on the session.
• 31.14 mld. CNY is the market capitalization, the total value of all outstanding shares; at this level the company is large-cap.
• -31 is the forward P/E ratio, calculated from expected earnings; a negative figure means the market expects losses.
• -6.24 CNY is the trailing 12-month EPS, meaning the company lost money on a per-share basis over the past year.
• 0% is the dividend yield, reflecting that Chongqing Zhifei Biological Products pays no cash dividend to shareholders.
• 0.46 is beta, a measure of volatility relative to the market; below 1 means the stock tends to move less than the broader market.
• 11.07 – 22.18 is the 52-week price range, showing the lowest and highest price seen over the past year.

What to watch

• Revenue growth, which is -27.2% year over year, can signal weakening demand or pricing pressure in the vaccine and biological products sector.
• Profitability metrics such as operating margin (-26.7%) and return on equity (-65.7%) show the company is currently unprofitable; investors often track these to see if a turnaround is developing.
• Debt-to-equity at 66.6% indicates moderate leverage; changes in this ratio can affect financial risk in the biotechnology industry.
• As a Shenzhen-listed stock, 300122 is part of the broader Chinese healthcare ecosystem that includes peers like Chang Chun High and New Technology Industry (Group) (000661) and Zhejiang NHU (002001).